Column Group Ii, Lp Arcus Biosciences, Inc. (RCUS) insider trading activity

RCUS Quotes by TradingView

Column Group Ii, LP is > 10% Shareholder of Arcus Biosciences, Inc.. Currently has a direct ownership of 470,427 shares of RCUS, which is worth approximately $7.29 Million. The most recent transaction as insider was on Mar 19, 2018, when has been sold 3,540,850 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 470K
0% 3M change
0% 12M change
Total Value Held $7.29 Million

COLUMN GROUP II, LP Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 19 2018
BUY
Conversion of derivative security
-
3,540,850 Added 88.27%
470,427 Common Stock

Also insider at

RAPT
RAPT Therapeutics, Inc. Healthcare
> 10% Shareholder
ORIC
Oric Pharmaceuticals, Inc. Healthcare
> 10% Shareholder
CGI

Column Group Ii, LP

> 10% Shareholder
San Francisco, CA

Track Institutional and Insider Activities on RCUS

Follow Arcus Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCUS shares.

Notify only if

Insider Trading

Get notified when an Arcus Biosciences, Inc. insider buys or sells RCUS shares.

Notify only if

News

Receive news related to Arcus Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RCUS